Last reviewed · How we verify

NCT05615155

Efficacy of C-PRF vs i-PRF in Thin Gingival Biotype Subjects

Completed NA Last updated 28 November 2023
What this trial tests

NA trial testing Platelets Rich Fibrin (i-PRF / C-PRF) in Thin Gingival Biotype in 10 participants. Completed in 1 November 2022.

Timeline
1 February 2022
Primary endpoint
1 November 2022
1 November 2022

Quick facts

Lead sponsorSajjad Ahmed Shakir
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingdouble
Primary purposetreatment
Enrollment10
Start date1 February 2022
Primary completion1 November 2022
Estimated completion1 November 2022
Sites1 location across Iraq

Drugs / interventions tested

Conditions studied

Sponsor

Sajjad Ahmed Shakir

Who can join

18 and older, any sex, with Thin Gingival Biotype. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized split mouth clinical trials study focused on comparing the efficacy of i-prf versus c-prf injections on gingival thickness and keratinized tissue width in subjects with thin gingival biotype.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Thin Gingival Biotype

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05615155.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing